Main > > >MEDICAL DIAGNOSTICS.

Automated EIA/IFA Processor.
QUANTA-Lyser 3000 is a fully automated EIA (enzyme linked immunoassay) and IFA (immunofluorescence assay) processor.
QUANTA-Lyser 3000 addresses many shortcomings of manual EIA and IFA processing. Existing methods for EIA and IFA testing currently utilized in many laboratories are time and labor-intensive and prone to transcription errors. The 240 capacity sample deck reduces the number of daily interventions while four independently operating probes provide fast turnaround time. The washable probes eliminate the need for costly disposable tips.
QUANTA-Lyser 3000 improves assay traceability for EIA and IFA protocols using an onboard camera that automatically scans 2D reagent barcodes. The 2D barcodes provide reagent identity, lot number and expiration date information from Inova Diagnostics reagents to ensure assay integrity. In addition, the camera automatically scans NOVA Lite® IFA slide barcodes to ensure positive patient identification throughout processing and creates a paperless workflow for EIA and IFA testing.
QUANTA-Lyser 3000 introduces individual well washing and the ability to pipette IFA slide mounting media to further automate testing. IFA slides are processed in proprietary carriers that can be directly transferred to NOVA View®, an automated digital IFA microscope, without the need to handle individual slides.
Company: Inova Diagnostics Inc. (www.inovadx.com)
Global Launch: 2017. 12.21.
UpDate: 2017. 12.23.




Blood Urea Nitrogen (BUN) and Total C02 Point-of-Care Testing.
Blood Urea Nitrogen and Total Carbon Dioxide testing at the point of care improve patient care with results in less than a minute.
Renal injury and metabolic diseases are common among critically ill patients who benefit from immediate results.
With the epoc system, these new assays will expand the patient information clinicians can access sooner to help rule in or rule out potential diagnoses more quickly.
BUN—combined with creatinine and an estimated glomular filtration rate (eGFR)—also available on the epoc system—can aid in the differential diagnosis of renal and metabolic diseases. TCO2—with other parameters that comprise a basic metabolic panel currently available at the point of care from Siemens Healthineers—can aid clinicians in assessing acid base and metabolic imbalances and make changes in therapy where necessary.
USA FDA Clearance Date: 2018. 02.01.
(*) Company : Siemens AG.>Siemens Healthineers.
TradeMark: Epoc
Web-Site : www.healthcare.siemens.com/point-of-care-
testing/blood-gas/blood-gas-systems/epoc-
blood-analysis-system/global/index.html
UpDate: 2018. 02.02.




Clinical Proteomics. Chromatographic
Analysis.
(*) Company; Patents & Web-Site Avai-
lable on Request.
UpDate: 2018. 08.19.




Depression>Diagnostics.
(*) Company; Patent; Product Name & Web-
Site Available on Request
UpDate: 2018. 05.03




IMAGING: CNS. MRI. in pediatric patients younger than two years of age. Contrast Agent:
Gadobenate Dimeglumine Inj.
USA Approval Date: 2018. 01.30.
(*) Company : Bracco Group>Bracco Diagnostics Inc.
TradeMark: MultiHance
UpDate: 2018. 01.31.




IMAGING: Head & Neck. Deep Learning SoftWare.
EU Approval Date: 2017. 11.27.
(*) Company Available on Request.
UpDate: 2017. 11.28.




Onco.>Lung Cancer>DIAG.: Computed Tomo-graphy (CT). Pulmonary Nodule Detecting Artificial Intelligence (AI) Solution.
JP Approval Date: 2019. 12.
KR Approval Date: 2020. 04.29.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 04.30.




Oral Fluid Collection Device.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 04.04.




SmartPhone Device.
Company is in the process of obtaining its CE mark and FDA 510k Clearance
(*) Company & Web-Site Available on Request.
UpDate: 2018. 02.24.




Tc-99m Generator.
RadioPharmaceuticals.
Used to produce sterile, Non-Pyrogenic Na Pertechnetate Tc 99m Injection.
Uses: - Brain Function Evaluation.
- Cancer Detection.
- Coronary Artery Disease Detection.
- Dacryoscintigraphy.
- Kidney Function Evaluation.
- Liver Function Evaluation.
- Lung Function Evaluation.
- Thyroid Imaging.
- Urinary Bladder Imaging (direct isotopic
cystography) for detection of vesicoureteral reflux.
USA Approval Date: 2018. 02.08.
(*) Company; Patents; TradeMark & Web-Site Available on
Request.
UpDate: 2018. 03.18.




Tc-99m. Production. (C)
RadioPharmaceuticals.
EU Approval Date: 2018. 08.08.
(*) Company; Patent & TradeMark Avai-
lable on Request.
UpDate: 2018. 08.09.


>MEDICAL DIAGNOSTICS.'s products
This section has no products